A photo of Russel Hirsch.

Director, Pulmonary Hypertension Service

Professor, UC Department of Pediatrics

513-636-7072

Board Certified

Best Doctors logo

About Me

Clinical Interests

Percutaneous interventions for the palliation or treatment of congenital heart disease; treatment of all forms of pediatric pulmonary hypertension; interventional catheterization; pulmonary hypertension; General Cardiology Outpatient Clinic

Research Interests

Device closure of congenital heart defects; feasibility of covered stent use in coarctation of the aorta; pulmonary vascular complications associated with congenital diaphragmatic hernia and chronic lung disease; cardiac manifestations of post bone-marrow transplant thrombotic microangiopathy; non-invasive evaluation of pulmonary hypertension in pediatric age patients; validation of new methods for assessing oxygen consumption in the cardiac catheterization laboratory

Academic Affiliation

Professor, UC Department of Pediatrics

Clinical Divisions

Heart, Hereditary Hemorrhagic Telangiectasia, Pulmonary Hypertension, Catheterization and Intervention, Bronchopulmonary Dysplasia BPD

My Locations

My Education

MBChB: University of Cape Town, Cape Town, South Africa.

Residency: St. Louis Children's Hospital, St. Louis, MO.

Fellowship: St. Louis Children's Hospital and Washington University School of Medicine, St. Louis, MO.

Certification: Pediatrics, 1994, 2002 (renew); Pediatric Cardiology, 1998, 2005.

My Publications

Impact of mechanical circulatory support on pediatric heart transplant candidates with elevated pulmonary vascular resistance. Thangappan, K; Morales, DL S; Vu, Q; Lehenbauer, D; Villa, C; Wittekind, S; Hirsch, R; Lorts, A; Zafar, F. Artificial Organs. 2021; 45:29-37.

Prognostic Value of Change in Cardiac Index After Prostacyclin Initiation in Pediatric Pulmonary Hypertension. Evers, PD; Critser, PJ; Cash, M; Magness, M; Hirsch, R. Pediatric Cardiology. 2021; 42:116-122.

Cardiovascular magnetic resonance imaging derived septal curvature in neonates with bronchopulmonary dysplasia associated pulmonary hypertension. Critser, PJ; Higano, NS; Lang, SM; Kingma, PS; Fleck, RJ; Hirsch, R; Taylor, MD; Woods, JC. Journal of Cardiovascular Magnetic Resonance. 2020; 22.

Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival. Griffiths, M; Yang, J; Nies, M; Vaidya, D; Brandal, S; Williams, M; Matsui, EC; Grant, T; Damico, R; Ivy, D; et al. Pediatric Research. 2020; 88:850-856.

Residence at moderately high altitude and its relationship with WHO Group 1 pulmonary arterial hypertension symptom severity and clinical characteristics: the Pulmonary Hypertension Association Registry. Fakhri, S; Hannon, K; Moulden, K; Peterson, R; Hountras, P; Bull, T; Maloney, J; De Marco, T; Ivy, D; Thenappan, T; et al. Pulmonary Circulation. 2020; 10.

Balloon atrial septostomy as initial therapy in pediatric pulmonary hypertension. Critser, PJ; Evers, PD; McGovern, E; Cash, M; Hirsch, R. Pulmonary Circulation. 2020; 10.

Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial Hypertension. Chen, JY; Griffiths, M; Yang, J; Nies, MK; Damico, RL; Simpson, CE; Vaidya, RD; Brandal, S; Ivy, DD; Austin, ED; et al. Journal of Pediatrics. 2020; 223:164-169.e1.

Cost-Utility of Sildenafil for Persistent Pulmonary Hypertension of the Newborn. Evers, PD; Critser, PJ; Cash, M; Magness, M; Hoelle, S; Hirsch, R. American Journal of Perinatology. 2020.

Pharmacokinetics of Oral Treprostinil in Children With Pulmonary Arterial Hypertension. Hopper, RK; Ivy, DD; Yung, D; Mullen, MP; Hanna, BD; Kirkpatrick, E; Hirsch, R; Austin, ED; Fineman, J; Solum, D; et al. Journal of Cardiovascular Pharmacology. 2020; 76:94-100.

Pulmonary vein stenosis: Treatment and challenges. Vanderlaan, RD; Rome, J; Hirsch, R; Ivy, D; Caldarone, CA. Journal of Thoracic and Cardiovascular Surgery. 2020.